FDA Go-Ahead For Sentinel TAVR Filter Could Drive Procedure Volumes, Firm Says

Claret Medical plans to start rolling out the TAVR accessory immediately at clinical trial centers, with full market release expected in 2018. The company is also trying to get a Medicare add-on payment.

A filter that helps cut the risk of stroke during transcatheter aortic valve replacement (TAVR) surgery is headed for the US market following an FDA thumbs-up.

Claret Medical Inc.’s SentinelCerebral Protection System was granted market access via the de novo classification process. It...

More from Approvals

More from Policy & Regulation